Fennec Pharmaceuticals Inc
FENC
|
|
| |
|
| Trading Volume | 8,265 |
|
|
11.61 - 5.32 |
| Market Cap Full | $ 147M |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | -5.7% | -3.2% | -0.9% | -13.3% |
| Q2 | - | -25.4% | -43.4% | 6.1% |
| Q3 | - | -25.4% | -16.9% | -15% |
| Q4 | - | -25.4% | 47.6% | 57.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| -3.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -11 | -5.2 | 17.4 | -16.2 | -27.2 | -9.6 | 8.2 | -16.9 | - | - | - | 4.7 |
| 2023 | |||||||||||
| 4.3 | -10.1 | -7.6 | -1.6 | -7.5 | 16.5 | 0.9 | -8.4 | -8 | -8.4 | 25 | 30.5 |
| 2022 | |||||||||||
| 5.4 | 20.2 | 0.2 | 3.1 | -1.3 | -2.1 | 18.6 | 5.7 | 15.7 | 8.6 | 10.9 | -1.6 |
| 2021 | |||||||||||
| -3.4 | 1.7 | -15.2 | 0.6 | 17.9 | -1.1 | -10.7 | 21.7 | 18.9 | -3.5 | -51.7 | 0.5 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.2 | -0.1 | -0.2 |
| Q2 | -0.2 | -0.2 | -0.2 |
| Q3 | -0.1 | -0.3 | -0.2 |
| Q4 | 0 | -0.3 | -0.2 |
| A | -0.51 | -0.9 | -0.7 |